Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Early treatment of acne is important to prevent scarring and improve appearance, using medications that can have side effects.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Nd:YAG laser can reduce hair with multiple treatments, but permanent removal isn't guaranteed.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.